The Immunotherapy Giant: Understanding the Keytruda Market

σε πρόσθεσε στο Health

2026-09-02 07:25:55 - Μετάφραση -

The Keytruda Market is a dominant and steadily growing segment of the global oncology pharmaceutical industry, centered on the blockbuster immunotherapy drug pembrolizumab. Keytruda is a programmed death receptor-1 (PD-1) inhibitor that works by harnessing the body's immune system to fight cancer cells. Currently valued at approximately USD 30.62 billion in 2025, this market is...

0 Σχόλια 0 Μοιράστηκε 187 Views 0 Προεπισκόπηση